VAPRISOL (nda021697)- (20MG/4ML (5MG/ML))

Generic Name	CONIVAPTAN HYDROCHLORIDE	Innovator	CUMBERLAND
Dosage	20MG/4ML (5MG/ML)
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2019-Dec-15	NCE Excl Expiry	2010-Dec-29
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	VAPRISOL ® is a vasopressin receptor antagonist indicated to raise serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
20MG/4ML (5MG/ML)	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of VAPRISOL